Semaglutide linked to significantly lower psychiatric risks in large Sweden and Australia studies
Two recent registry analyses from Sweden and Australia — together following nearly 100,000 adults, including more than 20,000 people who…
Petrelintide in Genentech’s Phase II ZUPREME-1 Trial: Meaningful Weight Loss, Slower Titration, and What Still Needs Proof
Genentech’s Phase II ZUPREME-1 trial suggests petrelintide is not a quick fix, but it may become a useful long-term obesity…